• Explore /
  • Poster
  • / Association of pretreatment CA19-9 with survival after 3-fraction SBRT for locally advanced pancreatic cancer: Results from a phase I dose-escalation trial.

Association of pretreatment CA19-9 with survival after 3-fraction SBRT for locally advanced pancreatic cancer: Results from a phase I dose-escalation trial.

Abstract Poster

Authors

null

Marsha Reyngold

Memorial Sloan Kettering Cancer Center, New York, NY

Marsha Reyngold , Sana Karam , Carla Hajj , Abraham Jing-Ching Wu , Paul Bernard Romesser , John J Cuaron , Ellen Yorke , Tracey E. Schefter , Bernard Jones , Yevgeniy Vinogradskiy , Christopher H. Crane , Karyn A. Goodman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02643498/NCT02873598

DOI

10.1200/JCO.2022.40.4_suppl.613

Abstract #

613

Poster Bd #

L8

Abstract Disclosures

Similar Posters

First Author: Mustafa Basree

First Author: Amit Jethanandani

First Author: Richard Tuli

First Author: Shun Tezuka